Skip to main content
. 2016 Feb 3;7(9):10193–10202. doi: 10.18632/oncotarget.7166

Table 2. PFS and OS: stratification of 107 patients into different groups with respect to hs-CRP changes.

PFS OS
No. patients No. events Median PFS (95% CI) p HR (95% CI) p No. events Median OS (95% CI) p HR (95% CI) p
Low-Low 58 48 12.6(10.2–16.0) 1.00 36 29.2(25.2–36.7) 1.00
Low-High 9 9 7.4(2.9–10.0) 2.84(1.37–5.88) 0.005 7 18.2(3.7–33.1) 2.37(1.05–5.37) 0.038
High-Low 28 25 9.1(8.9–11.4) 1.95(1.18–3.21) 0.009 21 15.0(13.1–23.3) 2.54(1.47–4.39) 0.0008
High-High 12 12 9.4(3.1–15.7) 0.002 2.14(1.13–4.08) 0.020 10 14.8(9.0–28.6) 0.0004 3.02(1.48–6.20) 0.002